Records real-world results of a heat-based device used in brain surgery for movement disorders
Collects outcomes of radiofrequency ablation devices in people with Parkinson disease, dystonia, or tremor.
Plain-language title generated from the registry record
Registry title: Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
Key facts
- Where
- Cologne, Düsseldorf, and Würzburg, GermanySee the 3 sites
Where in Germany
- Uniklinik KölnCologne, GermanyTaking people
- Universitaetsklinikum DusseldorfDüsseldorf, GermanyTaking people
- Universitaetsklinikum WuerzburgWürzburg, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Boston Scientific Corporation
- Trial code
- NCT06553625
- Record updated
- 13 October 2026
- Original description
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.Read full original descriptionShow less
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.
Inclusion: Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain or for CNS applications per local Directions for Use (DFU); Signed a valid, IRB/EC/REB-approved informed consent form.
Exclusion: Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments; Meets any contraindications per locally applicable Directions for Use (DFU).